launch of Wegovy pill, an oral semaglutide 25 mg once-daily formulation, following U.S
Because microdosing protocols are not standardized in the clinical literature, they require individualized physician oversight
Inject as close to the injured structure as you can safely reach with a subcutaneous needle
Preparing injectable tirzepatide Brand-name tirzepatide (Mounjaro, Zepbound) comes in pre-filled injection pens
Begin your personalized treatment plan with the support of our dedicated team
The dispersion between Novo and Lilly again goes to show the incredible power of competition to dictate stock outcomes: despite Novos excellent financial performance since 2023 (31% growth in 2023, 25% growth in 2024, 48% EBIT margins), the stock has declined because of competition: investors think Eli Lilly is the emerging winner within GLP-1s, given the stronger weight loss profile of tirzepatide (Mounjaro/Zepbound) versus semaglutide (Ozempic/Wegovy), and Lillys more attractive weight loss pipeline assets
